BioCentury
ARTICLE | Clinical News

Acuvail 0 regulatory update

July 27, 2009 7:00 AM UTC

Allergan said FDA approved an NDA for Acuvail ketorolac tromethamine ophthalmic solution to treat pain and inflammation following cataract surgery. Allergan expects to launch the ophthalmic formulatio...